Brief: Sesen Bio Says Participated In A Type B Meeting With FDA
12/07/2022 13:19
July 12 (Reuters) - Sesen Bio Inc SESN.O :
* SESEN BIO INC - ON JULY 11, 2022, CO PARTICIPATED IN A
TYPE B
MEETING WITH FDA
* SESEN BIO-DISCUSSED ITEMS ON PROPOSED PROTOCOL &
STATISTICAL
ANALYSIS PLAN DESIGN ELEMENTS FOR ADDITIONAL PHASE 3 CLINICAL
TRIAL FOR VICINEUM WITH FDA
Further company coverage: SESN.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Carisma Therapeutics
See all newsBrief: Carisma Therapeutics & Modernatx Amend Collaboration & And License Agreement - SEC Filing
Carisma Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Carisma Therapeutics Inc expected to post a loss of 9 cents a share - Earnings Preview
Brief: Carisma Therapeutics And Orthocellix Enter Into Definitive Merger Agreement
Carisma Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary